These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC). López Rubio M; Da Silva C; Loscertales J; Seri C; Baltasar P; Colado E; Pérez Fernández I; Osma M; Gomis F; González M; Jarque I; Vargas M; Monzó E; Monteagudo D; Orts MI; Pardal E; Carbonell F; Perez Calvo C; Garcia-Marco JA Leuk Lymphoma; 2014 May; 55(5):1007-12. PubMed ID: 23885799 [TBL] [Abstract][Full Text] [Related]
26. Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report. Buckstein R; Patel H; Chesney A; Reis M; Imrie K Hematology; 2006 Aug; 11(4):267-70. PubMed ID: 17178666 [TBL] [Abstract][Full Text] [Related]
27. Historical overview of hairy cell leukemia. Andritsos LA; Grever MR Best Pract Res Clin Haematol; 2015 Dec; 28(4):166-74. PubMed ID: 26614894 [TBL] [Abstract][Full Text] [Related]
28. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications. Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389 [TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Else M; Dearden CE; Matutes E; Garcia-Talavera J; Rohatiner AZ; Johnson SA; O'Connor NT; Haynes A; Osuji N; Forconi F; Lauria F; Catovsky D Br J Haematol; 2009 Jun; 145(6):733-40. PubMed ID: 19344416 [TBL] [Abstract][Full Text] [Related]
30. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616 [TBL] [Abstract][Full Text] [Related]
31. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia. Yang MH; Ho CH Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372 [TBL] [Abstract][Full Text] [Related]
32. Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis. Epperla N; Pavilack M; Olufade T; Bashyal R; Li J; Kabadi SM; Yuce H; Andritsos L Orphanet J Rare Dis; 2020 Feb; 15(1):47. PubMed ID: 32054500 [TBL] [Abstract][Full Text] [Related]
33. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia]. Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031 [TBL] [Abstract][Full Text] [Related]
34. Treatment Outcomes Of Patients With Hairy Cell Leukaemia; A 16-Year Experience At A Tertiary Care Center In Pakistan. Yousaf M; Khan MA; Iftikhar R; Chaudary QU; Shahbaz N; Ahmad U; Javed H J Ayub Med Coll Abbottabad; 2022; 34(4):797-801. PubMed ID: 36566402 [TBL] [Abstract][Full Text] [Related]
35. Rituximab in the treatment of the variant of hairy cell leukaemia: a case report. Hadzi-Pecova L; Stojanovik A; Petrusevska G; Panovska I Prilozi; 2008 Dec; 29(2):355-60. PubMed ID: 19259059 [TBL] [Abstract][Full Text] [Related]
36. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients. Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659 [TBL] [Abstract][Full Text] [Related]
37. Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. Hoffman MA; Janson D; Rose E; Rai KR J Clin Oncol; 1997 Mar; 15(3):1138-42. PubMed ID: 9060556 [TBL] [Abstract][Full Text] [Related]
38. Response to the Therapy in Hairy Cell Leukemia: Systematic Review and Meta-Analysis. Andrasiak I; Rybka J; Wrobel T Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):392-399.e3. PubMed ID: 29685423 [TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of 24 patients of hairy cell leukemia treated by cladribine]. Wang TY; Li ZJ; Lyu R; Fu MW; Sui WW; Huang WY; Liu W; An G; Deng SH; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):491-495. PubMed ID: 30032567 [No Abstract] [Full Text] [Related]